Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 2 8Phase 3 3Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Periampullary Cancer 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 28Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Pancreaticoduodenectomy × Gastrointestinal × Clear all
NCT05843877 2026-01-30

XandTX

Technische Universität Dresden

Phase 3 Recruiting
32 enrolled
Gastrointestinal

Periampullary Cancer

NCT03317886 2017-10-24

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Wakayama Medical University

Phase 3 Unknown
354 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT01419002 2015-07-29

Net-Pac

CHIR-Net

Phase 3 Terminated
5 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡